Partnership Opportunity To Identify Products for Fentanyl Exposure in Personal Protective Equipment Information Database; Reopening of the Comment Period, 731 [2019-00229]

Download as PDF Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services [CDC–2018–0085, Docket Number NIOSH– 319] [Document Identifier: CMS–10330, CMS– 10673, CMS–906, CMS–10433, CMS–276 and CMS–10694 and CMS–P–0015A] Partnership Opportunity To Identify Products for Fentanyl Exposure in Personal Protective Equipment Information Database; Reopening of the Comment Period Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Department of Health and Human Services. ACTION: Notice. AGENCY: National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice and reopening of comment period. AGENCY: On October 18, 2018 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the Federal Register [83 FR 52834] announcing the availability of a Partnership Opportunity to Identify Products for Fentanyl Exposure in Personal Protective Equipment Information Database. Written comments were to be received by November 19, 2018. In response to requests from interested parties, NIOSH is announcing the reopening of the comment period. DATES: Electronic or written comments must be received by April 1, 2019. FOR FURTHER INFORMATION CONTACT: ppeconcerns@cdc.gov, NIOSH, National Personal Protective Technology Laboratory, Office of the Director, 626 Cochrans Mill Road, Pittsburgh PA 15236, 1–888–654–2294 (a toll free number). SUMMARY: You may submit comments, identified by CDC–2018–0085 and Docket Number NIOSH–319, by either of the following two methods: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226–1998. amozie on DSK3GDR082PROD with NOTICES1 ADDRESSES: Dated: January 23, 2019. Frank J. Hearl, Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2019–00229 Filed 1–30–19; 8:45 am] BILLING CODE 4163–19–P VerDate Sep<11>2014 20:21 Jan 30, 2019 Jkt 247001 The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by April 1, 2019. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to http:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number lll, Room C4–26– SUMMARY: PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 731 05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at website address at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. 2. Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov. 3. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10330 Enrollment Opportunity Notice Relating to Lifetime Limits; Required Notice of Rescission of Coverage; and Disclosure Requirements for Patient Protection under the Affordable Care Act CMS–10379 Rate Increase Disclosure and Review Requirements (45 CFR part 154) CMS–10673 Medicare Advantage Qualifying Payment Arrangement Incentive (MAQI) Demonstration CMS–906 The Fiscal Soundness Reporting Requirements CMS–276 Prepaid Health Plan Cost Report CMS–10694 Testing of Web Survey Design and Administration for CMS Experience of Care Surveys CMS–P–0015A Medicare Current Beneficiary Survey Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing E:\FR\FM\31JAN1.SGM 31JAN1

Agencies

[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00229]



[[Page 731]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[CDC-2018-0085, Docket Number NIOSH-319]


Partnership Opportunity To Identify Products for Fentanyl 
Exposure in Personal Protective Equipment Information Database; 
Reopening of the Comment Period

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and reopening of comment period.

-----------------------------------------------------------------------

SUMMARY: On October 18, 2018 the National Institute for Occupational 
Safety and Health (NIOSH) of the Centers for Disease Control and 
Prevention (CDC), published a notice in the Federal Register [83 FR 
52834] announcing the availability of a Partnership Opportunity to 
Identify Products for Fentanyl Exposure in Personal Protective 
Equipment Information Database. Written comments were to be received by 
November 19, 2018. In response to requests from interested parties, 
NIOSH is announcing the reopening of the comment period.

DATES: Electronic or written comments must be received by April 1, 
2019.

FOR FURTHER INFORMATION CONTACT: ppeconcerns@cdc.gov, NIOSH, National 
Personal Protective Technology Laboratory, Office of the Director, 626 
Cochrans Mill Road, Pittsburgh PA 15236, 1-888-654-2294 (a toll free 
number).

ADDRESSES: You may submit comments, identified by CDC-2018-0085 and 
Docket Number NIOSH-319, by either of the following two methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: National Institute for Occupational Safety and 
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, 
Ohio 45226-1998.

    Dated: January 23, 2019.
Frank J. Hearl,
Chief of Staff, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2019-00229 Filed 1-30-19; 8:45 am]
 BILLING CODE 4163-19-P